Post‐COVID anxiety, depression, and quality of life among Egyptian hemodialysis patients

IF 1.5 4区医学 Q3 HEMATOLOGY

Therapeutic Apheresis and Dialysis Pub Date : 2024-04-17 DOI:10.1111/1744-9987.14128

Rehab AlSayed Shaban, Ahmed E. Abdulgalil, Ahmed Bahie

{"title":"Post‐COVID anxiety, depression, and quality of life among Egyptian hemodialysis patients","authors":"Rehab AlSayed Shaban, Ahmed E. Abdulgalil, Ahmed Bahie","doi":"10.1111/1744-9987.14128","DOIUrl":null,"url":null,"abstract":"IntroductionThis study examined the impact of Coronavirus disease 2019 on anxiety, depression, and health‐related quality of life (HRQOL) among Egyptian hemodialysis (HD) patients.MethodsThis multicenter cross‐sectional study was carried out in Egypt in the years 2021–2022, where 300 HD patients from four HD centers were allocated into two groups: post‐COVID and non‐COVID. The Hospital Anxiety and Depression Scale (HADS) and the Kidney Disease QOL‐36 questionnaire were used to assess anxiety, depression, and QOL of the included patients.ResultsIn the post‐COVID group, abnormal and borderline cases of anxiety and depression were detected in 38.6% and 62.5% of patients, respectively, with no statistically significant difference between both groups. The post‐COVID group showed higher work status and lower sexual and physical functioning, which correlated negatively with anxiety and depression scores.ConclusionPast‐COVID infection did not influence depression and anxiety symptoms in HD patients. Sexual and physical functioning were more affected among COVID‐survivors.","PeriodicalId":23021,"journal":{"name":"Therapeutic Apheresis and Dialysis","volume":"27 1","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2024-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Apheresis and Dialysis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/1744-9987.14128","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

IntroductionThis study examined the impact of Coronavirus disease 2019 on anxiety, depression, and health‐related quality of life (HRQOL) among Egyptian hemodialysis (HD) patients.MethodsThis multicenter cross‐sectional study was carried out in Egypt in the years 2021–2022, where 300 HD patients from four HD centers were allocated into two groups: post‐COVID and non‐COVID. The Hospital Anxiety and Depression Scale (HADS) and the Kidney Disease QOL‐36 questionnaire were used to assess anxiety, depression, and QOL of the included patients.ResultsIn the post‐COVID group, abnormal and borderline cases of anxiety and depression were detected in 38.6% and 62.5% of patients, respectively, with no statistically significant difference between both groups. The post‐COVID group showed higher work status and lower sexual and physical functioning, which correlated negatively with anxiety and depression scores.ConclusionPast‐COVID infection did not influence depression and anxiety symptoms in HD patients. Sexual and physical functioning were more affected among COVID‐survivors.

查看原文本刊更多论文

埃及血液透析患者在 COVID 后的焦虑、抑郁和生活质量

导言本研究探讨了2019年冠状病毒病对埃及血液透析（HD）患者焦虑、抑郁和健康相关生活质量（HRQOL）的影响。方法这项多中心横断面研究于2021-2022年在埃及开展，来自4个HD中心的300名HD患者被分为两组：COVID后和非COVID。研究采用医院焦虑抑郁量表（HADS）和肾脏病 QOL-36 问卷来评估纳入患者的焦虑、抑郁和 QOL。COVID后组患者的工作状态较高，性功能和身体功能较低，这与焦虑和抑郁评分呈负相关。COVID幸存者的性功能和身体功能受到的影响更大。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Therapeutic Apheresis and Dialysis 医学-泌尿学与肾脏学

CiteScore

3.00

自引率

10.50%

发文量

166

审稿时长

6-12 weeks

期刊介绍： Therapeutic Apheresis and Dialysis is the official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis and the Japanese Society for Dialysis Therapy. The Journal publishes original articles, editorial comments, review articles, case reports, meeting abstracts and Communications information on apheresis and dialysis technologies and treatments.